<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02839980</url>
  </required_header>
  <id_info>
    <org_study_id>NI15006</org_study_id>
    <nct_id>NCT02839980</nct_id>
  </id_info>
  <brief_title>Microbial Epidemiology and Chlorhexidine Suscebtibily of Oropharyngeal and Intestinal Colonization</brief_title>
  <acronym>OroColi</acronym>
  <official_title>Comparative Microbial Epidemiology and Chlorhexidine Suscebtibily of Oropharyngeal and Intestinal Colonization of Hospital Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this prospective observational multicenter study we aim to determine the prevalence of
      oropharyngeal and rectal Gram-negative bacilli colonization in 4 population of hospitalized
      subjects, and their susceptibility to chlorehexidine. We plan to recruit 300 subjects in
      surgical wards (100 in orthopedics, 100 in thoracic and vascular, 100 in abdominal surgery)
      and 100 in the ICU. Secondary endpoints are to determine the incidence of the acquisition of
      such colonization in a 10-day timeframe; determine the phylogentic characteristics of E. coli
      isolates; to compare the phylogentic characteristics of oropharyngeal and rectal E. coli
      isolates; to compare the phylogentic characteristics of colonization and potential E. coli
      infection isolates; to compare the rectal and oropharyngeal colonization composition;
      description of oropharyngeal microbiote
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this prospective multicenter observational study we aim to determine the prevalence of
      oropharyngeal and rectal Gram-negative bacilli colonization in 4 population of hospitalized
      subjects, and their susceptibility to chlorehexidine. We plan to recruit 300 subjects in
      surgical wards (100 in orthopedics, 100 in thoracic and vascular, 100 in abdominal surgery)
      and 100 in the ICU. Each participant will undego a oropharyngeal swab collection at day 0,
      day 5 and day 10 (or discharge), and a rectal swab at day 0 and day 10 or hospital discharge.
      The Gram-negative bacilli colonization will be identified, E. coli isolates will be studied
      in terms of phylogeny, antimicrobial and chlorhexidine susceptibility. The primary endpoint
      is to determine the prevalence of oropharyngeal and rectal Gram-negative bacilli
      colonization. The secondary endpoints are to determine the incidence of the acquisition of
      such colonization in a 10 days timeframe; to determine the phylogentic characteristics of E.
      coli isolates; to compare the phylogentic characteristics of oropharyngeal and rectal E. coli
      isolates; to compare the phylogentic characteristics of colonization and potential E. coli
      infection isolates; to compare the rectal and oropharyngeal colonization composition;
      description of oropharyngeal microbiote.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>proportion of patients with a gram-negative colonization at admission</measure>
    <time_frame>day 1</time_frame>
    <description>proportion of patients in whom admission oropahryngeal sample will contain at least one gram-negative bacilli among Haemophilus influenzae, an enterobacteria, or a non-fermenting GNB.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>incidence of the acquisition of a oropharyngela or rectal GNB colonization</measure>
    <time_frame>during hospital stay or 10 days if still hospitalized</time_frame>
    <description>incidence of the acquisition of a oropharyngela or rectal GNB colonization in the 4 populations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>comparison of the predominant fecal flora with GNB oropharyngeal colonization</measure>
    <time_frame>hospital stay or 10 days if still hospitalized</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>characterization of antimicrobial and chlorhexidine susceptibility of gram-negative isolates from oropharyngeal colonization</measure>
    <time_frame>hospital stay or 10 days if still hospitalized</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>phylogenetic and virulence factor content of E. coli oropharyngeal and rectal colonization</measure>
    <time_frame>hospital stay or 10 days if still hospitalized</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>comparision of the genetic identity of the dominant E. coli rectal and orpohayrngeal colonization with potential nosocomial infections</measure>
    <time_frame>hospital stay or 10 days if still hospitalized</time_frame>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Oropharyngeal Gram-negative Bacilli Colonization</condition>
  <arm_group>
    <arm_group_label>orthopedics (gr1) surgery</arm_group_label>
    <description>parient admitted to the orthopedics (gr1) surgery ward for an elective or semi-emergent surgical procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>thoracic (gr2) surgery</arm_group_label>
    <description>parient admitted to the thoracic (gr2) surgery ward for an elective or semi-emergent surgical procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>abdominal (gr3) surgery</arm_group_label>
    <description>parient admitted to the abdominal (gr3) surgery ward for an elective or semi-emergent surgical procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ICU (gr4)</arm_group_label>
    <description>patients admitted to the ICU with an antcipated length of stay of 3 days or more</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted in wards in which emergence of multi-drug resistant bacteria justifies a
        regular monitoring (i.e. surgical wards and ICU)
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt; 18 years old

          -  admitted in one of the participating surgery wards for elective or semi-emergent
             surgerical procedure or in one of the ICUs;

          -  for an anticipated length of stay of 72h

        Exclusion Criteria:

          -  personal history of neck or face irradiation

          -  bronchectasis;

          -  patient's or proxies' opposition to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jonathan MESSIKA, MD,</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hopital Louis Mourier - Assistance Publique Hopitaux de Paris</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jonathan MESSIKA, MD</last_name>
    <phone>+331 47 60 63 29</phone>
    <email>jonathan.messika@aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jean-Damien RICARD, MD, Ph D</last_name>
    <phone>+331 47 60 61 91</phone>
    <email>jean-damien.ricard@aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>AP-HP, Louis Mourier Hospital</name>
      <address>
        <city>Colombes</city>
        <state>Ile De France</state>
        <zip>92700</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>jonathan MESSIKA, MD</last_name>
      <email>jonathan.messika@aphp.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 19, 2016</study_first_submitted>
  <study_first_submitted_qc>July 20, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 21, 2016</study_first_posted>
  <last_update_submitted>January 18, 2018</last_update_submitted>
  <last_update_submitted_qc>January 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>oropharyngeal colonization</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine</mesh_term>
    <mesh_term>Chlorhexidine gluconate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

